Accretion Pharmaceuticals Ltd
₹
None%
- close price
About
[
edit about
]
[
add key points
]
- Market Cap ₹ 112 Cr.
- Current Price ₹
- High / Low ₹ /
- Stock P/E 75.4
- Book Value ₹
- Dividend Yield %
- ROCE %
- ROE %
- Face Value ₹ 10.0
Pros
Cons
- Company has high debtors of 159 days.
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Sector: Pharmaceuticals Industry: Pharmaceuticals - Indian - Bulk Drugs & Formln
Loading peers table ...
Quarterly Results
Figures in Rs. Crores
Operating Profit |
OPM % |
Interest |
Depreciation |
Profit before tax |
Tax % |
EPS in Rs |
Raw PDF |
Profit & Loss
Figures in Rs. Crores
Mar 2024 5m | |
---|---|
13.35 | |
10.71 | |
Operating Profit | 2.64 |
OPM % | 19.78% |
0.05 | |
Interest | 0.47 |
Depreciation | 0.22 |
Profit before tax | 2.00 |
Tax % | 25.00% |
1.49 | |
EPS in Rs | 3.72 |
Dividend Payout % | 0.00% |
Compounded Sales Growth | |
---|---|
10 Years: | % |
5 Years: | % |
3 Years: | % |
TTM: | % |
Compounded Profit Growth | |
---|---|
10 Years: | % |
5 Years: | % |
3 Years: | % |
TTM: | % |
Stock Price CAGR | |
---|---|
10 Years: | % |
5 Years: | % |
3 Years: | % |
1 Year: | % |
Return on Equity | |
---|---|
10 Years: | % |
5 Years: | % |
3 Years: | % |
Last Year: | % |
Balance Sheet
Figures in Rs. Crores
Mar 2024 | |
---|---|
Equity Capital | 4.00 |
Reserves | 1.49 |
13.48 | |
7.90 | |
Total Liabilities | 26.87 |
5.25 | |
CWIP | 0.00 |
Investments | 0.00 |
21.62 | |
Total Assets | 26.87 |
Cash Flows
Figures in Rs. Crores
Mar 2024 | |
---|---|
-11.44 | |
-5.48 | |
17.01 | |
Net Cash Flow | 0.09 |
Ratios
Figures in Rs. Crores
Mar 2024 | |
---|---|
Debtor Days | 158.58 |
Inventory Days | 564.06 |
Days Payable | 256.32 |
Cash Conversion Cycle | 466.31 |
Working Capital Days | 369.10 |
ROCE % |
Documents
Annual reports
No data available.